Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
New trends
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Alcohol and drug treatment
Young people, students and families
Infectious diseases — New trends
Monitoring — New trends
New trends — Vulnerable groups
Public health — New trends
Wednesday, 23 October
10:50
High-risk drug use and health threats in Eastern Europe
Focus on the EU borders
10:50
to
12:20
Central square 3 (C3)
Katri Abel-Ollo
Anne Bergenström
Understanding and improving health and social outcomes
10:50
to
12:20
Networking zone 3 (N3)
Sanna Rönkä
Stimulants — use, harm and interventions
10:50
to
12:20
Networking zone 4 (N4)
Janusz Sieroslawski
13:20
Nicotine harm reduction
13:20
to
14:50
Networking zone 4 (N4)
Ann McNeill
Poster guided tour
Problematic gaming and digital media use - ISSBA poster session 1
13:20
to
14:50
Guided poster tours room
Patrick Trotzke
The challenges of monitoring new drugs
13:20
to
14:50
Insights zone 2 (I2)
Ana Gallegos
15:00
New psychoactive substances
15:00
to
16:30
Networking zone 3 (N3)
Pierluigi Simonato
Prevention strategies
15:00
to
16:30
Insights zone 2 (I2)
Angelina Brotherhood
Therapeutic horizons I
15:00
to
16:30
Networking zone 1 (N1)
Wouter Vanderplasschen
16:50
Issues, challenges and future perspectives
Gender and drugs in Europe
16:50
to
18:20
Networking zone 1 (N1)
Alessandra Liquori
Linda Montanari
18:30
Workforce development and training
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Thursday, 24 October
10:50
Understanding behaviours, risks and harms
10:50
to
12:20
Networking zone 3 (N3)
Xavier Majó
Monitoring trends and developments
10:50
to
12:20
Insights zone 1 (I1)
Larissa Maier
13:20
Infusing policy with evidence
13:20
to
14:50
Central square 3 (C3)
Lara Tavoschi
Reducing drug-related deaths
13:20
to
14:50
Central square 2 (C2)
Catherine Comiskey
Treatment adherence
13:20
to
14:50
Insights zone 4 (I4)
Marta Torrens Melich
Using new technology and innovative methods to measure substance use and related harm
13:20
to
14:50
Networking zone 1 (N1)
Peter Reuter
15:00
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
16:50
Emerging drug trends in North Africa and Middle East
Focus on the EU borders
16:50
to
18:20
Insights zone 2 (I2)
Ioanna Yiasemi
Thomas Néfau
Trends and harms related to recreational drugs, prescription medicines and new psychoactive substances
European Drug Emergency Network Plus (Euro-DEN Plus)
16:50
to
18:20
Main stage
Nicola Singleton
Gambling research
16:50
to
18:20
Networking zone 1 (N1)
Luke Clark
18:30
Nightlife, festivals and other recreational settings
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Friday, 25 October
10:45
Monitoring drug trends in the EU and Australia using digital and online instruments
10:45
to
12:15
Futures zone 1 (F1)
Matthijs Blankers
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:55
Oral presentation
Dynamics in emerging drug use prevalence among people who inject drugs in Ukraine between 2013 and 2017
10:55
to
11:10
Central square 3 (C3)
Slava Kushakov
11:00
Short communication
Portuguese gender-sensitive harm reduction services: bridging the gap
11:00
to
11:10
Networking zone 3 (N3)
Short communication
Do more people in Europe need treatment for problems related to cocaine use? An analysis of cocaine treatment demand in nine European countries
11:00
to
11:10
Networking zone 4 (N4)
Antoine Jérôme
11:10
Short communication
A change in the prescribing practice of prebagalin that has had a direct negative effect on drug-induced deaths in Ireland
11:10
to
11:20
Networking zone 3 (N3)
Ena Lynn
Short communication
Psychostimulant induce neuronal plasticity by cytoskeleton remodeling via cdc42 pathway
11:10
to
11:20
Networking zone 4 (N4)
Andrea Lobo
Oral presentation
Patterns of NPS consumption and perceived risks and benefits: results of online survey in Georgia
11:10
to
11:25
Central square 3 (C3)
David Otiashvili
11:25
Oral presentation
Research on the use of new psychoactive substances and challenges in responding to it in Moldova (Eastern Europe)
11:25
to
11:40
Central square 3 (C3)
Eliza Kurcevic
11:30
Short communication
Performance enhancing drugs. Results from a Belgian survey on PED use among workers
11:30
to
11:40
Networking zone 3 (N3)
Marie-Claire Lambrechts
11:40
Short communication
Drug and alcohol treatment: how much does it cost in Europe?
11:40
to
11:50
Networking zone 3 (N3)
Claudia Costa Storti
Short communication
Crackland in Brazil: epidemiological monitoring method and results
11:40
to
11:50
Networking zone 4 (N4)
Clarice Madruga
Oral presentation
Drug use, HIV, HCV, including in prisons, in Eastern Europe: trends and implications for policy and programmes
11:40
to
11:55
Central square 3 (C3)
Lyuba Azbel
11:50
Short communication
Young people's exposure to gambling advertisements: a mixed methods study in Australia.
11:50
to
12:00
Networking zone 3 (N3)
Hannah Pitt
Short communication
'I have no clue why I’m doing this' – a qualitative study on crack cocaine use in Frankfurt, Germany
11:50
to
12:00
Networking zone 4 (N4)
Bernd Werse
12:00
Short communication
Street Work Nursing as an innovative strategy in the care for dually diagnosed individuals: reflections on a pilot study
12:00
to
12:10
Networking zone 3 (N3)
Ilse Goethals
12:10
Short communication
Dissuasion, the effectiveness of the intervention and good practices
12:10
to
12:20
Networking zone 3 (N3)
Américo Gegaloto
13:20
Poster
The effectiveness of prevention programs for problematic usage of internet in adolescents and youths: a systematic review
13:20
to
14:50
Guided poster tours room
Silvana Romero
Poster
Obsessive compulsive disorder and internet gaming disorder
13:20
to
14:50
Guided poster tours room
Marisa Martins
Poster
Internet gaming: hobby or behavioral addiction?
13:20
to
14:50
Guided poster tours room
Ana Samouco
Poster
New addictions, new risks: sexting behaviours as a result of internet addiction
13:20
to
14:50
Guided poster tours room
Manuel Jesús Ruiz Muñoz
Poster
Cybersex, mental health and intimacy: an exploratory study with a population in treatment of substance use disorders
13:20
to
14:50
Guided poster tours room
Teodomiro Miguel B. F. Urbano Pires
Poster
Interrelationships between smartphone addiction, affect, sleep quality, and sexual problems: preliminary findings in a nonclinical female sample
13:20
to
14:50
Guided poster tours room
Rui Costa
Poster
Internet addiction is related to distortion of time perception assessed by the Perception of Time Online Scale (PTO)
13:20
to
14:50
Guided poster tours room
Rita de Sousa Lopes
Poster
The association of alexithymia and internet gaming disorder in a clinical German sample
13:20
to
14:50
Guided poster tours room
Magdalena Pape
Poster
Internet addiction correlates with online sexual behaviours
13:20
to
14:50
Guided poster tours room
Rui Costa
Poster
Gamification: Promoting healthy online behavior among 5-12 years children through a game
13:20
to
14:50
Guided poster tours room
Ivone Patrão
13:30
Short communication
Smokeless tobacco (snus) use and intergenerational social mobility among adolescents during 10 years
13:30
to
13:40
Networking zone 4 (N4)
Oral presentation
The advantages and challenges of developing a national earlier warning system - Transforming Bergen Earlier Warning System (BEWS) into Norwegian National Earlier Warning System (NNEWS).
13:30
to
13:45
Insights zone 2 (I2)
Else Kristin Utne Berg
13:40
Short communication
Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of past-year smokers
13:40
to
13:50
Networking zone 4 (N4)
Erikas Simonavicius
13:45
Oral presentation
New psychoactive substances in Portugal
13:45
to
14:00
Insights zone 2 (I2)
Ludmila Carapinha
13:50
Short communication
Co-use and co-quitting: predicting motivation to quit tobacco and cannabis among further education college students in the UK
13:50
to
14:00
Networking zone 4 (N4)
Hannah Walsh
14:00
Short communication
Implementation of financial incentives for successful smoking cessation in real-life company settings
14:00
to
14:10
Networking zone 4 (N4)
Gera Nagelhout
Oral presentation
Recent use of synthetic cannabinoids, synthetic opioids and other psychoactive drug groups among high-risk drug users in Israel.
14:00
to
14:15
Insights zone 2 (I2)
Barak Shapira
14:10
Short communication
Challenges in tobacco control in Serbia
14:10
to
14:20
Networking zone 4 (N4)
Biljana Kilibarda
14:15
Oral presentation
Use of physiologically based pharmacokinetic modelling of new psychoactive substances
14:15
to
14:30
Insights zone 2 (I2)
Nuno Elvas Silva
14:30
Oral presentation
Combining monitoring data to evaluate responses to NPS: the case of 4-FA in the Netherlands
14:30
to
14:45
Insights zone 2 (I2)
Margriet van Laar
15:10
Short communication
Insights into benzo fury toxicity: 5-(2-aminopropyl)benzofuran and 6-(2-aminopropyl)benzofuran disrupt oxidative, energetic and mitochondrial homeostasis of hepatocytes in vitro
15:10
to
15:20
Networking zone 3 (N3)
Rita Roque Bravo
Oral presentation
A peer-led integrated approach for co-existing mental and addictive disorders: a longitudinal qualitative study of the first UK dual diagnosis anonymous
15:10
to
15:25
Networking zone 1 (N1)
Raffaella Margherita Milani
Oral presentation
Recognising that behaviour is often automatic, contingent on environmental cues and with limited self-regulation: the potentials of environmental prevention
15:10
to
15:25
Insights zone 2 (I2)
Gregor Burkhart
15:20
Short communication
Tracking NPS in Portugal: the case of MTMP
15:20
to
15:30
Networking zone 3 (N3)
Helena Gaspar
15:25
Oral presentation
m-Health among illicit drug users: effectiveness, differential indication, risks and negative effects and ongoing developments among guided and unguided interventions
15:25
to
15:40
Networking zone 1 (N1)
Michael Schaub
Oral presentation
Invalidating adolescents' pro-cannabis opinions: a new tactic of prevention
15:25
to
15:40
Insights zone 2 (I2)
William Crano
15:30
Short communication
Single binge dosing of 4-Methylethcathinone (4-MEC) induces sturdy and durable cognitive impairment in mice
15:30
to
15:40
Networking zone 3 (N3)
Cristina Sampayo
15:40
Short communication
Abuse potential of new psychoactive substances: N-ethylhexedrone, 4-Methylethcathinone, 4-Fluoromethcathinone and Buphedrone
15:40
to
15:50
Networking zone 3 (N3)
Cristina Sampayo
Oral presentation
Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans
15:40
to
15:55
Networking zone 1 (N1)
Meryem Grabski
Oral presentation
IDART- a national study on targeted injury prevention
15:40
to
15:55
Insights zone 2 (I2)
Benedicte Joergenrund
15:50
Short communication
Studies on the metabolism of synthetic cathinones N-ethylhexedrone and buphedrone using liquid chromatography-mass spectrometry (LC-MS/MS)
15:50
to
16:00
Networking zone 3 (N3)
Joana Carrola
15:55
Oral presentation
The acceptability of psychedelics as treatment options in psychiatry. Data from GDS2019
15:55
to
16:10
Networking zone 1 (N1)
Adam Winstock
Oral presentation
Results of the EPOPS project: adaptation, implementation and evaluation of a programme empowering parents organisations for alcohol prevention in Spain and Portugal
15:55
to
16:10
Insights zone 2 (I2)
Cátia Magalhães
16:00
Short communication
Changa – fist time identification in Portugal
16:00
to
16:10
Networking zone 3 (N3)
Maria João Caldeira
16:10
Short communication
Variations and determinants of novel psychoactive substance use: a mixed methods study to identify the implications for policy and practice
16:10
to
16:20
Networking zone 3 (N3)
Kathryn Higgins
Oral presentation
Effectiveness and cost-effectiveness of adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
16:10
to
16:25
Networking zone 1 (N1)
John Marsden
Oral presentation
Adolescents in need - study of the origin and demands of adolescents and youngsters arriving at West Lisbon CRI indicated prevention locals
16:10
to
16:25
Insights zone 2 (I2)
Isabel Prata Duarte
16:50
Oral presentation
Drug use, drug related problems and responses among women in Europe: latest European data
16:50
to
18:20
Networking zone 1 (N1)
Eleni Kalamara
Oral presentation
Female-oriented medicosocial responses in French drug treatment facilities. Results from the Ad-femina survey
16:50
to
18:20
Networking zone 1 (N1)
Carine Mutatayi
Oral presentation
Violence and substance use among women
16:50
to
18:20
Networking zone 1 (N1)
Florence Mabileau
Ourania Botsi
Panellists
16:50
to
18:20
Networking zone 1 (N1)
Franca Beccaria
Brendan Hughes
Analia Torres
Sharon Arpa
Linda Lombi
18:30
Short communication
The peer in outreach teams: a specialist among specialists?
18:30
to
18:40
Networking zone 3 (N3)
Maria João Oliveira
18:40
Short communication
The Akan-model: a Norwegian model for preventing and handling alcohol, drugs and gambling problems in the workplace
18:40
to
18:50
Networking zone 3 (N3)
Camilla Lynne Bakkeng
18:50
Short communication
Experiences of marketised welfare organisations among addiction treatment staff in Sweden
18:50
to
19:00
Networking zone 3 (N3)
Jessica Storbjörk
19:00
Short communication
Preparing effective addiction workforce: a challenge from the Czech perspective
19:00
to
19:10
Networking zone 3 (N3)
Amalie Pavlovská
19:10
Short communication
Workforce development: the great paradox for the addictions sector
19:10
to
19:20
Networking zone 3 (N3)
Ann Roche
19:20
Short communication
Evidence-based practice and its many competing priorities: a qualitative analysis of substance misuse workers in English third-sector addiction treatment services
19:20
to
19:30
Networking zone 3 (N3)
Robert Calder
Thursday, 24 October
11:00
Short communication
Neuropsychological functioning, psychopathology, and parenting behaviours in the context of substance use disorders: which are the implications for treatment?
11:00
to
11:10
Networking zone 3 (N3)
Alessio Porreca
Oral presentation
Prevalence of injecting and non-injecting high-risk opioid use in Switzerland over more than two decades: understanding associations with opioid agonist treatment and needle and syringe programs
11:00
to
11:15
Insights zone 1 (I1)
Carlos Nordt
11:10
Short communication
Childhood adversity within adolescent friendship groups: Implications for subsequent substance use disorders
11:10
to
11:20
Networking zone 3 (N3)
Lauren Bishop
11:15
Oral presentation
20 years of communication on drugs: What are the new challenges for a monitoring centre?
11:15
to
11:30
Insights zone 1 (I1)
Julie-Emilie Ades
11:20
Short communication
Cause-specific hospitalisation and death in a cohort of people who use heroin and crack cocaine in London, England: the importance of non-communicable diseases, skin infections, head injuries and dental caries
11:20
to
11:40
Networking zone 3 (N3)
Dan Lewer
11:30
Short communication
Yearning to be better than good –Lithuanian students of medicine use of cognitive enhancers among
11:30
to
11:40
Networking zone 3 (N3)
Aiste Lengvenyte
Oral presentation
Monitoring local drug trends – looking back at 17 years of 'Monitoring system drug trends' in Frankfurt, Germany
11:30
to
11:45
Insights zone 1 (I1)
Bernd Werse
11:40
Short communication
New issues regarding drug-related deaths: combined suicide
11:40
to
11:50
Networking zone 3 (N3)
Mateja Jandl
11:45
Oral presentation
Implementing treatment demand indicator in West Africa: challenges and lessons learnt
11:45
to
12:00
Insights zone 1 (I1)
Dominique Lopez
11:50
Short communication
Women and HIV in prison setting: data from the Italian ROSE network
11:50
to
12:00
Networking zone 3 (N3)
12:00
Short communication
Non-national clients in Belgian drug treatment: different profile characteristics compared to Belgian clients
12:00
to
12:10
Networking zone 3 (N3)
Charlotte De Kock
Oral presentation
An Australian clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern
12:00
to
12:15
Insights zone 1 (I1)
Krista J. Siefried
13:30
Oral presentation
'A more accurate understanding of drug use': a critical analysis of wastewater analysis technology for drug policy
13:30
to
13:45
Networking zone 1 (N1)
Kari Lancaster
Oral presentation
Use of contingency management (positive reinforcement with financial incentives) to encourage abstinence from heroin (PRAISE): a UK cluster randomised trial
13:30
to
13:45
Insights zone 4 (I4)
Nicola Metrebian
Timothy Weaver
Oral presentation
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
13:30
to
13:45
Central square 2 (C2)
John Marsden
Oral presentation
Translating research into policy: is 'advocacy' a dirty word?
13:30
to
13:45
Central square 3 (C3)
Alison Ritter
13:45
Oral presentation
Beyond the substances: a multi-criteria analysis of spread of drugs in Europe
13:45
to
14:00
Networking zone 1 (N1)
Giuliano Resce
Oral presentation
Opioid maintenance treatment (OMT) – not life-long for all women? 10 years follow-up after pregnancy - how many stop OMT and what are the results?
13:45
to
14:00
Insights zone 4 (I4)
Gabrielle Welle-Strand
Oral presentation
Results of mortality cohort study of problem drug users in Poland.
13:45
to
14:00
Central square 2 (C2)
Janusz Sieroslawski
Oral presentation
Addiction practitioners and drug policy reform
13:45
to
14:00
Central square 3 (C3)
Kasia Malinowska-Sempruch
14:00
Oral presentation
A smartphone app to assess alcohol consumption behaviours: development, validity, compliance and reactivity
14:00
to
14:15
Networking zone 1 (N1)
Rob Hester
Oral presentation
A look at the dark side of addiction treatment: a profile of those who drop out
14:00
to
14:15
Insights zone 4 (I4)
João Augusto
Oral presentation
Individual vulnerability as core risk factor for gambling disorder: implications for public health and gambling policies
14:00
to
14:15
Central square 3 (C3)
Gerhard Bühringer
Oral presentation
Nasal naloxone for overdose prevention in Norway: results from the first four years
14:00
to
14:15
Central square 2 (C2)
Oral presentation
Nasal naloxone for overdose prevention in Norway: results from the first four years
14:00
to
14:15
Central square 2 (C2)
Desiree Eide
14:15
Oral presentation
New and fully automated workflow for alcohol consumption and drugs of abuse monitoring from one single blood droplet
14:15
to
14:30
Networking zone 1 (N1)
Marc Luginbühl
Oral presentation
Methadone serum concentrations and influencing factors: a naturalistic observational study
14:15
to
14:30
Insights zone 4 (I4)
Fatemeh Chalabianloo
Oral presentation
Incidence and predictors of drug overdoses among a cohort of patients treated for substance use disorder
14:15
to
14:30
Central square 2 (C2)
Birgitte Thylstrup
Oral presentation
Drug use in rural and suburban environments: challenges in a progressive drug policy setting
14:15
to
14:30
Central square 3 (C3)
Ludmila Carapinha
14:30
Oral presentation
Is methadone treatment more effective for lower socio-economic status opiate users? Results from a case crossover study in Lazio
14:30
to
14:45
Insights zone 4 (I4)
Antonella Camposeragna
Oral presentation
MDMA-related deaths in Australia
14:30
to
14:45
Central square 2 (C2)
Amanda Roxburgh
Oral presentation
Application of a preliminary 'qualitative' leximetric approach via an example: anti-drug laws, policies and social outcomes in Italy since 2000.
14:30
to
14:45
Central square 3 (C3)
Carla Rossi
15:10
Oral presentation
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands
15:10
to
15:25
Insights zone 4 (I4)
Daan van der Gouwe
15:40
Oral presentation
A descriptive analysis of the illicit supply of new psychoactive substances within and from China
15:40
to
15:55
Insights zone 4 (I4)
Minqi Zhao
15:55
Oral presentation
MDMA dosage in XTC tablets: size matters
15:55
to
16:10
Insights zone 4 (I4)
Ruben Vrolijk
16:10
Oral presentation
Understanding drug markets: results of the MARSTUP study
16:10
to
16:25
Insights zone 4 (I4)
Frank Zobel
17:00
Oral presentation
The European Drug Emergencies Network Plus (Euro-DEN Plus) project: what has it shown us over the last 5 years?
17:00
to
17:15
Main stage
Isabelle Giraudon
Oral presentation
'I shouldn’t have taken that bet!': counterfactual thinking in gambling disorder
17:00
to
17:15
Networking zone 1 (N1)
Luke Clark
Oral presentation
Framing the non-medical use of tramadol in Africa- global opioid crises, medicrime or inadequate healthcare systems
17:00
to
17:20
Insights zone 2 (I2)
Axel Klein
17:15
Oral presentation
Prescription medicine misuse and related acute toxicity
17:15
to
17:30
Main stage
Alison Dines
Oral presentation
Income-related inequality in gambling: evidence from Italy
17:15
to
17:30
Networking zone 1 (N1)
Giuliano Resce
17:20
Oral presentation
Captagon: knowns and unknows
17:20
to
17:35
Insights zone 2 (I2)
Laurent Laniel
17:30
Oral presentation
Comparison of the acute harms of the synthetic cannabinoids and cannabis
17:30
to
17:45
Main stage
Christopher Yates
Oral presentation
Socio-ecological model of problem gambling: a cross-national comparison on young people in the United States, South Korea, Spain and Finland
17:30
to
17:45
Networking zone 1 (N1)
Atte Oksanen
17:35
Oral presentation
Libya’s changing drug trafficking dynamics on the coastal and desert borders
17:35
to
17:50
Insights zone 2 (I2)
Mark Micallef
17:45
Oral presentation
Clinical coding of acute drug and NPS presentations: why doesn’t it work and what can be done
17:45
to
18:00
Main stage
David Wood
Oral presentation
Online poker : loss of control and gambling disorder
17:45
to
18:00
Networking zone 1 (N1)
Axelle Moreau
17:50
Oral presentation
Harm reduction services in MENA region: Assessment of the situation and response by MENAHRA
17:50
to
18:05
Insights zone 2 (I2)
Elie Aaraj
18:00
Oral presentation
Marketing stimuli and their perceived effects among sports bettors in treatment for gambling disorder
18:00
to
18:15
Networking zone 1 (N1)
Hibai Lopez-Gonzalez
18:05
Oral presentation
Wastewater-based drug epidemiology data in selected community compared to a forensic toxicology investigation finding. Sewage sensors towards evaluation of drug use trends
18:05
to
18:20
Insights zone 2 (I2)
Bilel Moslah
18:40
Short communication
Recommendations for NPS-targeted initiatives in Belgium
18:40
to
18:50
Networking zone 3 (N3)
Anton van Dijck
18:50
Short communication
Predicting the onset of ketamine use among frequent nightlife attendees
18:50
to
19:00
Networking zone 3 (N3)
Charlotte van Miltenburg
19:00
Short communication
Why a zero tolerance drug policy for festivals is not working (well)
19:00
to
19:10
Networking zone 3 (N3)
Jochen Schrooten
19:10
Short communication
Towards gender-sensitive responses in the drugs field: Intersections between sexual violence, drug use in nightlife environments
19:10
to
19:20
Networking zone 3 (N3)
Cristiana Vale Pires
19:20
Short communication
Setting up a HPLC in a 7-day psychedelic music festival: drug checking moving forward
19:20
to
19:30
Networking zone 3 (N3)
Daniel Martins
Friday, 25 October
10:45
Oral presentation
Development and contribution to software to monitor online discussions on internet drug discussion forums
10:45
to
12:15
Futures zone 1 (F1)
Magali Martinez
Oral presentation
Trends in the online availability of fentanyl (analogues) in Australia and the impact of policy interventions (2012-2019)
10:45
to
12:15
Futures zone 1 (F1)
Amy Peacock
Oral presentation
Routine internet forum monitoring for new psychoactive substances: implementation of the EC funded I-TREND project results
10:45
to
12:15
Futures zone 1 (F1)
Daan van der Gouwe
Oral presentation
Automated monitoring of online shops offering new psychoactive substances in the EU
10:45
to
12:15
Futures zone 1 (F1)
Martin Pazitny
Vendula Belackova
Oral presentation
4-Fluoramphetamine in the Netherlands: Text-mining and sentiment analysis of internet drug discussion forums
10:45
to
12:15
Futures zone 1 (F1)
Matthijs Blankers